← All Startups
Boundless Bio Series C
Precision oncology therapeutic
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Location
La Jolla, CA
Stage
Series C
Website
boundlessbio.com
LinkedIn
View profile
BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Founders
P
Paul Mischel, MD ’91
LinkedIn
Similar Startups
Centivax
Broad-spectrum vaccine
Stephanie Wisner ’16, ,
Patientory
Web3 for health data
Chrissa McFarlane ’11, ,
Latent Series A
Medical language models for healthcare overhead
Rishabh Jain ’17, ,
SimpliFed Series A
Baby breastfeeding virtual care
Andrea Ippolito ’06, MEng ’07, ,
ModMed
Software for specialty medical practices
Daniel Cane ’98, ,
Obsidian Therapeutics Series C
Cell and gene therapies
Vic Myer ’89, Jeffrey Trigilio ’06,